Jounce Therapeutics, Inc.

CIK 1640455 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Jounce Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2024SC 13G/A0001172661-24-000930
Feb 9, 2024SC 13G0001493152-24-005665
Feb 2, 2024SC 13G/A0001085146-24-000646
May 15, 202315-12G0001640455-23-000117
May 5, 202340001209191-23-027692
May 5, 202330001209191-23-027685
May 5, 2023SC 13D/A0001214659-23-006565
May 5, 202340001209191-23-027688
May 4, 20238-K0001640455-23-000093
May 4, 2023S-8 POS0001640455-23-000103
May 4, 2023S-8 POS0001640455-23-000101
May 4, 2023S-8 POS0001640455-23-000100
May 4, 2023EFFECT9999999995-23-001275
May 4, 202340001640455-23-000110
May 4, 2023SC 14D9/A0001640455-23-000084
May 4, 202325-NSE0001354457-23-000336
May 4, 2023EFFECT9999999995-23-001276
May 4, 202340001640455-23-000107
May 4, 202340001640455-23-000114
May 4, 2023POS AM0001640455-23-000098
May 4, 2023S-8 POS0001640455-23-000102
May 4, 202340001640455-23-000111
May 4, 202340001640455-23-000113
May 4, 2023S-8 POS0001640455-23-000104
May 4, 202340001640455-23-000112